BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 36579548)

  • 1. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
    Bowirrat A
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
    Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
    Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the neuroinflammation hypothesis in Alzheimer's disease: a focus on the druggability of current targets.
    Wong-Guerra M; Calfio C; Maccioni RB; Rojo LE
    Front Pharmacol; 2023; 14():1161850. PubMed ID: 37361208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pro-inflammatory cytokines in Alzheimer's disease].
    Stamouli EC; Politis AM
    Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer's Disease.
    Yan H; Wang W; Cui T; Shao Y; Li M; Fang L; Feng L
    Immunotargets Ther; 2024; 13():287-304. PubMed ID: 38881647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer's Disease.
    Marttinen M; Takalo M; Natunen T; Wittrahm R; Gabbouj S; Kemppainen S; Leinonen V; Tanila H; Haapasalo A; Hiltunen M
    Front Neurosci; 2018; 12():963. PubMed ID: 30618585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobiology of Alzheimer's disease.
    Mohandas E; Rajmohan V; Raghunath B
    Indian J Psychiatry; 2009 Jan; 51(1):55-61. PubMed ID: 19742193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain capillaries in Alzheimer's disease.
    Baloyannis SJ
    Hell J Nucl Med; 2015; 18 Suppl 1():152. PubMed ID: 26665235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging-Dependent Mitophagy Dysfunction in Alzheimer's Disease.
    Song M; Zhao X; Song F
    Mol Neurobiol; 2021 May; 58(5):2362-2378. PubMed ID: 33417222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease.
    Yang Y; Zhang Z
    Front Aging Neurosci; 2020; 12():110. PubMed ID: 32477095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer's Disease.
    Xu YJ; Au NPB; Ma CHE
    Front Aging Neurosci; 2022; 14():896852. PubMed ID: 35693341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research Progress of Targeting Neuro-Immune Inflammation in the Treatment of Alzheimer's Disease.
    Chen H; Deng C; Meng Z; Meng S
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):312. PubMed ID: 36472107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.